TreeWAS – Variant ID: rs12788102

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
H40.9 Glaucoma, unspecified	0.000	0.855	0.145
H40 Glaucoma	0.000	0.874	0.126
H40.0 Glaucoma suspect	0.000	0.878	0.122
H40.5 Glaucoma secondary to other eye disorders	0.000	0.894	0.106
H40.8 Other glaucoma	0.000	0.907	0.093
H40.6 Glaucoma secondary to drugs	0.000	0.909	0.091
H40.4 Glaucoma secondary to eye inflammation	0.000	0.909	0.091
H40.3 Glaucoma secondary to eye trauma	0.000	0.909	0.091
T39.1 4-Aminophenol derivatives	0.089	0.911	0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.088	0.912	0.000
H40.2 Primary angle-closure glaucoma	0.000	0.917	0.083
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.082	0.918	0.000
T42.4 Benzodiazepines	0.079	0.921	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.078	0.922	0.000
T36-T50 Poisoning by drugs, medicaments and biological substances	0.077	0.923	0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.067	0.933	0.000
T39.0 Salicylates	0.066	0.934	0.000
H40.1 Primary open-angle glaucoma	0.000	0.934	0.066
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.064	0.936	0.000
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.063	0.937	0.000
T39.4 Antirheumatics, not elsewhere classified	0.063	0.937	0.000
T39.2 Pyrazolone derivatives	0.063	0.937	0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.062	0.938	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.060	0.940	0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.060	0.940	0.000
T42.0 Hydantoin derivatives	0.059	0.941	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.059	0.941	0.000
T40.2 Other opioids	0.059	0.941	0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.058	0.942	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.056	0.944	0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.056	0.944	0.000
T42.5 Mixed antiepileptics, not elsewhere classified	0.056	0.944	0.000
T42.3 Barbiturates	0.056	0.944	0.000
T42.2 Succinimides and oxazolidinediones	0.056	0.944	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.055	0.945	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.055	0.945	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.055	0.945	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.055	0.945	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.055	0.945	0.000
H40-H42 Glaucoma	0.000	0.947	0.053
T45.1 Antineoplastic and immunosuppressive drugs	0.051	0.949	0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.050	0.950	0.000
T36 Poisoning by systemic antibiotics	0.049	0.950	0.000
T42.1 Iminostilbenes	0.048	0.952	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.047	0.953	0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.046	0.954	0.000
T47.4 Other laxatives	0.045	0.954	0.000
T50.6 Antidotes and chelating agents, not elsewhere classified	0.045	0.955	0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.044	0.955	0.000
T40.8 Lysergide [LSD]	0.044	0.955	0.000
T40.7 Cannabis (derivatives)	0.044	0.955	0.000
T40.5 Cocaine	0.044	0.955	0.000
T40.3 Methadone	0.044	0.955	0.000
T40.1 Heroin	0.044	0.955	0.000
T40.0 Opium	0.044	0.955	0.000
T46.4 Angiotensin-converting-enzyme inhibitors	0.044	0.956	0.000
C91.1 Chronic lymphocytic leukaemia	0.044	0.956	0.000
T45.9 Primarily systemic and haematological agent, unspecified	0.043	0.957	0.000
T45.8 Other primarily systemic and haematological agents	0.043	0.957	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.043	0.957	0.000
T45.6 Fibrinolysis-affecting drugs	0.043	0.957	0.000
T45.4 Iron and its compounds	0.043	0.957	0.000
T45.3 Enzymes, not elsewhere classified	0.043	0.957	0.000
T45.2 Vitamins, not elsewhere classified	0.043	0.957	0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.042	0.957	0.000
T46.8 Antivaricose drugs, including sclerosing agents	0.042	0.957	0.000
T46.7 Peripheral vasodilators	0.042	0.957	0.000
T46.5 Other antihypertensive drugs, not elsewhere classified	0.042	0.957	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.042	0.957	0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.042	0.957	0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.042	0.957	0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.042	0.958	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.042	0.958	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.042	0.958	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.042	0.958	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.042	0.958	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.042	0.958	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.042	0.958	0.000
T44.0 Anticholinesterase agents	0.042	0.958	0.000
T45.0 Antiallergic and antiemetic drugs	0.041	0.959	0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.040	0.959	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.040	0.959	0.000
T47.7 Emetics	0.040	0.959	0.000
T47.6 Antidiarrhoeal drugs	0.040	0.959	0.000
T47.5 Digestants	0.040	0.959	0.000
T47.3 Saline and osmotic laxatives	0.040	0.959	0.000
T47.2 Stimulant laxatives	0.040	0.959	0.000
T47.0 Histamine H(2)-receptor antagonists	0.040	0.959	0.000
T45.5 Anticoagulants	0.040	0.960	0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.040	0.960	0.000
T37.8 Other specified systemic anti-infectives and antiparasitics	0.040	0.960	0.000
T37.5 Antiviral drugs	0.040	0.960	0.000
T37.4 Anthelminthics	0.040	0.960	0.000
T37.3 Other antiprotozoal drugs	0.040	0.960	0.000
T37.2 Antimalarials and drugs acting on other blood protozoa	0.040	0.960	0.000
T37.1 Antimycobacterial drugs	0.040	0.960	0.000
T37.0 Sulphonamides	0.040	0.960	0.000
T41.5 Therapeutic gases	0.040	0.960	0.000
T41.4 Anaesthetic, unspecified	0.040	0.960	0.000
T41.3 Local anaesthetics	0.040	0.960	0.000
T41.2 Other and unspecified general anaesthetics	0.040	0.960	0.000
T41.1 Intravenous anaesthetics	0.040	0.960	0.000
T41.0 Inhaled anaesthetics	0.040	0.960	0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.040	0.960	0.000
T48.6 Antiasthmatics, not elsewhere classified	0.040	0.960	0.000
T48.5 Anti-common-cold drugs	0.040	0.960	0.000
T48.4 Expectorants	0.040	0.960	0.000
T48.3 Antitussives	0.040	0.960	0.000
T48.2 Other and unspecified agents primarily acting on muscles	0.040	0.960	0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.040	0.960	0.000
T48.0 Oxytocic drugs	0.040	0.960	0.000
T49.9 Topical agent, unspecified	0.040	0.960	0.000
T49.8 Other topical agents	0.040	0.960	0.000
T49.7 Dental drugs, topically applied	0.040	0.960	0.000
T49.6 Otorhinolaryngological drugs and preparations	0.040	0.960	0.000
T49.5 Ophthalmological drugs and preparations	0.040	0.960	0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.040	0.960	0.000
T49.3 Emollients, demulcents and protectants	0.040	0.960	0.000
T49.2 Local astringents and local detergents	0.040	0.960	0.000
T49.1 Antipruritics	0.040	0.960	0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.040	0.960	0.000
T50.8 Diagnostic agents	0.040	0.960	0.000
T50.7 Analeptics and opioid receptor antagonists	0.040	0.960	0.000
T50.5 Appetite depressants	0.040	0.960	0.000
T50.4 Drugs affecting uric acid metabolism	0.040	0.960	0.000
T50.3 Electrolytic, caloric and water-balance agents	0.040	0.960	0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.040	0.960	0.000
T50.1 Loop [high-ceiling] diuretics	0.040	0.960	0.000
T50.0 Mineralocorticoids and their antagonists	0.040	0.960	0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.040	0.960	0.000
H42 Glaucoma in diseases classified elsewhere	0.000	0.962	0.038
T40.6 Other and unspecified narcotics	0.036	0.963	0.000
C91 Lymphoid leukaemia	0.036	0.964	0.000
T36.9 Systemic antibiotic, unspecified	0.036	0.964	0.000
T36.8 Other systemic antibiotics	0.036	0.964	0.000
T36.7 Antifungal antibiotics, systemically used	0.036	0.964	0.000
T36.6 Rifamycins	0.036	0.964	0.000
T36.5 Aminoglycosides	0.036	0.964	0.000
T36.4 Tetracyclines	0.036	0.964	0.000
T36.3 Macrolides	0.036	0.964	0.000
T36.2 Chloramphenicol group	0.036	0.964	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.036	0.964	0.000
T47.1 Other antacids and anti-gastric-secretion drugs	0.035	0.965	0.000
T46.1 Calcium-channel blockers	0.034	0.966	0.000
T38.9 Other and unspecified hormone antagonists	0.034	0.966	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.034	0.966	0.000
T38.7 Androgens and anabolic congeners	0.034	0.966	0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.034	0.966	0.000
T38.5 Other oestrogens and progestogens	0.034	0.966	0.000
T38.4 Oral contraceptives	0.034	0.966	0.000
T38.2 Antithyroid drugs	0.034	0.966	0.000
T38.0 Glucocorticoids and synthetic analogues	0.034	0.966	0.000
T38.1 Thyroid hormones and substitutes	0.034	0.966	0.000
T50.9 Other and unspecified drugs, medicaments and biological substances	0.032	0.967	0.000
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue	0.032	0.968	0.000
C83 Diffuse non-Hodgkin's lymphoma	0.031	0.969	0.000
T36.0 Penicillins	0.030	0.970	0.000
C90 Multiple myeloma and malignant plasma cell neoplasms	0.030	0.970	0.000
C83.8 Other types of diffuse non-Hodgkin's lymphoma	0.030	0.970	0.000
C88 Malignant immunoproliferative diseases	0.029	0.970	0.000
T40.4 Other synthetic narcotics	0.029	0.971	0.000
C83.0 Small cell (diffuse)	0.028	0.972	0.000
H42.8 Glaucoma in other diseases classified elsewhere	0.000	0.972	0.027
H42.0 Glaucoma in endocrine, nutritional and metabolic diseases	0.000	0.972	0.027
C91.0 Acute lymphoblastic leukaemia	0.027	0.973	0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.026	0.973	0.000
C90.0 Multiple myeloma	0.027	0.973	0.000
C88.0 Waldenstrom's macroglobulinaemia	0.026	0.974	0.000
C91.8 Mature B-cell leukaemia Burkitt-type	0.026	0.974	0.000
C91.7 Other lymphoid leukaemia	0.026	0.974	0.000
C91.6 Prolymphocytic leukaemia of T-cell type	0.026	0.974	0.000
C91.5 Adult T-cell leukaemia	0.026	0.974	0.000
C91.3 Prolymphocytic leukaemia	0.026	0.974	0.000
C91.2 Subacute lymphocytic leukaemia	0.026	0.974	0.000
C81 Hodgkin's disease	0.026	0.974	0.000
C90.1 Plasma cell leukaemia	0.026	0.974	0.000
C91.9 Lymphoid leukaemia, unspecified	0.025	0.974	0.000
C92 Myeloid leukaemia	0.025	0.975	0.000
C93 Monocytic leukaemia	0.025	0.975	0.000
C88.4 Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma]	0.024	0.976	0.000
C83.9 Diffuse non-Hodgkin's lymphoma, unspecified	0.024	0.976	0.000
C95 Leukaemia of unspecified cell type	0.024	0.976	0.000
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.023	0.976	0.000
C94 Other leukaemias of specified cell type	0.023	0.976	0.000
C86 Other specified types of T/NK-cell lymphoma	0.023	0.976	0.000
C90.2 Plasmacytoma, extramedullary	0.023	0.977	0.000
C83.6 Undifferentiated (diffuse)	0.022	0.978	0.000
C83.5 Lymphoblastic (diffuse)	0.022	0.978	0.000
C83.4 Immunoblastic (diffuse)	0.022	0.978	0.000
C83.2 Mixed small and large cell (diffuse)	0.022	0.978	0.000
C83.1 Small cleaved cell (diffuse)	0.022	0.978	0.000
C91.4 Hairy-cell leukaemia	0.022	0.978	0.000
C90.3 Solitary plasmacytoma	0.022	0.978	0.000
C83.7 Burkitt's tumour	0.021	0.978	0.000
C88.9 Malignant immunoproliferative disease, unspecified	0.021	0.979	0.000
C88.7 Other malignant immunoproliferative diseases	0.021	0.979	0.000
C88.3 Immunoproliferative small intestinal disease	0.021	0.979	0.000
C88.2 Gamma heavy chain disease	0.021	0.979	0.000
C88.1 Alpha heavy chain disease	0.021	0.979	0.000
C92.0 Acute myeloid leukaemia	0.021	0.979	0.000
C81.2 Mixed cellularity	0.020	0.980	0.000
C81.9 Hodgkin's disease, unspecified	0.020	0.980	0.000
C93.1 Chronic monocytic leukaemia	0.019	0.981	0.000
C84 Peripheral and cutaneous T-cell lymphomas	0.019	0.981	0.000
C81.7 Other Hodgkin's disease	0.018	0.981	0.000
C81.4 Lymphocyte-rich classical Hodgkin lymphoma	0.018	0.981	0.000
C81.3 Lymphocytic depletion	0.018	0.981	0.000
C81.0 Lymphocytic predominance	0.018	0.981	0.000
C92.9 Myeloid leukaemia, unspecified	0.018	0.982	0.000
C92.8 Acute myeloid leukaemia with multilineage dysplasia	0.018	0.982	0.000
C92.7 Other myeloid leukaemia	0.018	0.982	0.000
C92.6 Acute myeloid leukaemia with 11q23-abnormality	0.018	0.982	0.000
C92.5 Acute myelomonocytic leukaemia	0.018	0.982	0.000
C92.3 Myeloid sarcoma	0.018	0.982	0.000
C92.2 Subacute myeloid leukaemia	0.018	0.982	0.000
C92.4 Acute promyelocytic leukaemia	0.018	0.982	0.000
C85 Other and unspecified types of non-Hodgkin's lymphoma	0.018	0.982	0.000
C93.9 Monocytic leukaemia, unspecified	0.018	0.982	0.000
C93.7 Other monocytic leukaemia	0.018	0.982	0.000
C93.3 Juvenile myelomonocytic leukaemia	0.018	0.982	0.000
C93.2 Subacute monocytic leukaemia	0.018	0.982	0.000
C93.0 Acute monocytic leukaemia	0.018	0.982	0.000
C81.1 Nodular sclerosis	0.018	0.982	0.000
C95.9 Leukaemia, unspecified	0.017	0.983	0.000
C95.7 Other leukaemia of unspecified cell type	0.017	0.983	0.000
C95.2 Subacute leukaemia of unspecified cell type	0.017	0.983	0.000
C95.1 Chronic leukaemia of unspecified cell type	0.017	0.983	0.000
C95.0 Acute leukaemia of unspecified cell type	0.017	0.983	0.000
C86.6 Primary cutaneous CD30-positive T-cell proliferations	0.017	0.983	0.000
C86.5 Angioimmunoblastic T-cell lymphoma	0.017	0.983	0.000
C86.4 Blastic NK-cell lymphoma	0.017	0.983	0.000
C86.3 Subcutaneous panniculitis-like T-cell lymphoma	0.017	0.983	0.000
C86.2 Enteropathy-type (intestinal) T-cell lymphoma	0.017	0.983	0.000
C86.1 Hepatosplenic T-cell lymphoma	0.017	0.983	0.000
C86.0 Extranodal NK/T-cell lymphoma, nasal type	0.017	0.983	0.000
C94.7 Other specified leukaemias	0.017	0.983	0.000
C94.6 Myelodysplastic and myeloproliferative disease, not elsewhere classified	0.017	0.983	0.000
C94.5 Acute myelofibrosis	0.017	0.983	0.000
C94.4 Acute panmyelosis	0.017	0.983	0.000
C94.3 Mast cell leukaemia	0.017	0.983	0.000
C94.2 Acute megakaryoblastic leukaemia	0.017	0.983	0.000
C94.1 Chronic erythraemia	0.017	0.983	0.000
C94.0 Acute erythraemia and erythroleukaemia	0.017	0.983	0.000
C96.9 Malignant neoplasms of lymphoid, haematopoietic and related tissue, unspecified	0.017	0.983	0.000
C96.8 Histiocytic sarcoma	0.017	0.983	0.000
C96.7 Other specified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.017	0.983	0.000
C96.6 Unifocal Langerhans-cell histiocytosis	0.017	0.983	0.000
C96.5 Multifocal and unisystemic Langerhans-cell histiocytosis	0.017	0.983	0.000
C96.4 Sarcoma of dendritic cells (accessory cells)	0.017	0.983	0.000
C96.3 True histiocytic lymphoma	0.017	0.983	0.000
C96.2 Malignant mast cell tumour	0.017	0.983	0.000
C96.1 Malignant histiocytosis	0.017	0.983	0.000
C96.0 Letterer-Siwe disease	0.017	0.983	0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.017	0.983	0.000
C92.1 Chronic myeloid leukaemia	0.016	0.984	0.000
C85.1 B-cell lymphoma, unspecified	0.016	0.984	0.000
C84.9 Mature T/NK-cell lymphoma, unspecified	0.014	0.986	0.000
C84.8 Cutaneous T-cell lymphoma, unspecified	0.014	0.986	0.000
C84.7 Anaplastic large cell lymphoma, ALK-negative	0.014	0.986	0.000
C84.6 Anaplastic large cell lymphoma, ALK-positive	0.014	0.986	0.000
C84.3 Lymphoepithelioid lymphoma	0.014	0.986	0.000
C84.2 T-zone lymphoma	0.014	0.986	0.000
C84.1 Sezary's diease	0.014	0.986	0.000
C84.0 Mycosis fungoides	0.014	0.986	0.000
C85.2 Mediastinal (thymic) large B-cell lymphoma	0.013	0.987	0.000
C85.0 Lymphosarcoma	0.013	0.987	0.000
C84.4 Peripheral T-cell lymphoma	0.013	0.987	0.000
S62.61 Fracture of other finger (open)	0.012	0.988	0.000
T43.4 Butyrophenone and thioxanthene neuroleptics	0.012	0.988	0.000
T43.9 Psychotropic drug, unspecified	0.012	0.988	0.000
T43.8 Other psychotropic drugs, not elsewhere classified	0.012	0.988	0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.012	0.988	0.000
I44.2 Atrioventricular block, complete	0.011	0.989	0.000
Y43.3 Other antineoplastic drugs	0.011	0.989	0.000
T43.6 Psychostimulants with abuse potential	0.011	0.989	0.000
C85.7 Other specified types of non-Hodgkin's lymphoma	0.011	0.989	0.000
C84.5 Other and unspecified T-cell lymphomas	0.010	0.990	0.000
C82 Follicular [nodular] non-Hodgkin's lymphoma	0.010	0.990	0.000
T43.5 Other and unspecified antipsychotics and neuroleptics	0.010	0.990	0.000
T43.0 Tricyclic and tetracyclic antidepressants	0.010	0.990	0.000
S62.6 Fracture of other finger	0.010	0.990	0.000
T43.3 Phenothiazine antipsychotics and neuroleptics	0.009	0.991	0.000
G57.6 Lesion of plantar nerve	0.008	0.992	0.000
O34.2 Maternal care due to uterine scar from previous surgery	0.008	0.992	0.000
S62.60 Fracture of other finger (closed)	0.008	0.992	0.000
C82.2 Large cell, follicular	0.008	0.992	0.000
R31 Unspecified haematuria	0.000	0.992	0.008
G57.1 Meralgia paraesthetica	0.008	0.992	0.000
C82.3 Follicular lymphoma grade IIIa	0.007	0.992	0.000
C82.6 Cutaneous follicle centre lymphoma	0.007	0.992	0.000
C82.5 Diffuse follicle centre lymphoma	0.007	0.992	0.000
C82.4 Follicular lymphoma grade IIIb	0.007	0.992	0.000
G57 Mononeuropathies of lower limb	0.008	0.992	0.000
S62.3 Fracture of other metacarpal bone	0.007	0.993	0.000
S62 Fracture at wrist and hand level	0.007	0.993	0.000
C67 Malignant neoplasm of bladder	0.000	0.993	0.007
C82.1 Mixed small cleaved and large cell, follicular	0.006	0.993	0.000
C67.6 Ureteric orifice	0.000	0.993	0.007
S62.30 Fracture of other metacarpal bone (closed)	0.007	0.993	0.000
C82.0 Small cleaved cell, follicular	0.006	0.993	0.000
C67.9 Bladder, unspecified	0.000	0.993	0.007
H65.9 Nonsuppurative otitis media, unspecified	0.007	0.993	0.000
C83.3 Large cell (diffuse)	0.006	0.994	0.000
S62.31 Fracture of other metacarpal bone (open)	0.006	0.994	0.000
S14.1 Other and unspecified injuries of cervical spinal cord	0.006	0.994	0.000
E23.0 Hypopituitarism	0.006	0.994	0.000
G57.3 Lesion of lateral popliteal nerve	0.006	0.994	0.000
C67.0 Trigone of bladder	0.000	0.994	0.006
G57.8 Other mononeuropathies of lower limb	0.006	0.994	0.000
S14 Injury of nerves and spinal cord at neck level	0.006	0.994	0.000
G57.0 Lesion of sciatic nerve	0.006	0.994	0.000
C82.7 Other types of follicular non-Hodgkin's lymphoma	0.005	0.994	0.000
C67.2 Lateral wall of bladder	0.000	0.994	0.006
G57.9 Mononeuropathy of lower limb, unspecified	0.006	0.994	0.000
G57.4 Lesion of medial popliteal nerve	0.006	0.994	0.000
G57.2 Lesion of femoral nerve	0.006	0.994	0.000
S10 Superficial injury of neck	0.006	0.994	0.000
S10-S19 Injuries to the neck	0.006	0.994	0.000
S10.9 Superficial injury of neck, part unspecified	0.005	0.995	0.000
S62.8 Fracture of other and unspecified parts of wrist and hand	0.005	0.995	0.000
C67.4 Posterior wall of bladder	0.000	0.995	0.005
S62.1 Fracture of other carpal bone(s)	0.005	0.995	0.000
C67.3 Anterior wall of bladder	0.000	0.995	0.005
H65 Nonsuppurative otitis media	0.005	0.995	0.000
C67.8 Overlapping lesion of bladder	0.000	0.995	0.005
C67.7 Urachus	0.000	0.995	0.005
S62.5 Fracture of thumb	0.005	0.995	0.000
T43.2 Other and unspecified antidepressants	0.005	0.995	0.000
N47 Redundant prepuce, phimosis and paraphimosis	0.005	0.995	0.000
G57.5 Tarsal tunnel syndrome	0.005	0.995	0.000
Chapter XIX Injury, poisoning and certain other consequences of external causes	0.005	0.995	0.000
S62.7 Multiple fractures of fingers	0.005	0.995	0.000
S62.2 Fracture of first metacarpal bone	0.005	0.995	0.000
E21.0 Primary hyperparathyroidism	0.000	0.995	0.005
S62.4 Multiple fractures of metacarpal bones	0.005	0.995	0.000
E23.2 Diabetes insipidus	0.005	0.995	0.000
S14.3 Injury of brachial plexus	0.005	0.995	0.000
E23 Hypofunction and other disorders of pituitary gland	0.005	0.995	0.000
M19.01 Primary arthrosis of other joints (Shoulder region)	0.005	0.995	0.000
S30-S39 Injuries to the abdomen, lower back, lumbar spine and pelvis	0.005	0.995	0.000
C85.9 Non-Hodgkin's lymphoma, unspecified type	0.005	0.995	0.000
S10.8 Superficial injury of other parts of neck	0.005	0.995	0.000
T20-T25 Burns and corrosions of external body surface, specified by site	0.005	0.995	0.000
Q51.3 Bicornate uterus	0.005	0.995	0.000
C67.5 Bladder neck	0.000	0.995	0.005
S62.51 Fracture of thumb (open)	0.005	0.995	0.000
C67.1 Dome of bladder	0.000	0.995	0.005
H65.3 Chronic mucoid otitis media	0.005	0.995	0.000
S62.0 Fracture of navicular [scaphoid] bone of hand	0.004	0.995	0.000
C64-C68 Malignant neoplasms of urinary tract	0.000	0.995	0.005
S14.6 Injury of other and unspecified nerves of neck	0.004	0.995	0.000
S14.5 Injury of cervical sympathetic nerves	0.004	0.995	0.000
S14.4 Injury of peripheral nerves of neck	0.004	0.995	0.000
S14.2 Injury of nerve root of cervical spine	0.004	0.995	0.000
S14.0 Concussion and oedema of cervical spinal cord	0.004	0.995	0.000
T20 Burn and corrosion of head and neck	0.004	0.995	0.000
H25.1 Senile nuclear cataract	0.000	0.995	0.005
T00-T07 Injuries involving multiple body regions	0.004	0.995	0.000
N42.8 Other specified disorders of prostate	0.004	0.996	0.000
S13 Dislocation, sprain and strain of joints and ligaments at neck level	0.004	0.996	0.000
S39 Other and unspecified injuries of abdomen, lower back and pelvis	0.004	0.996	0.000
T20.0 Burn of unspecified degree of head and neck	0.004	0.996	0.000
H66.9 Otitis media, unspecified	0.004	0.996	0.000
H65.1 Other acute nonsuppurative otitis media	0.004	0.996	0.000
T93.2 Sequelae of other fractures of lower limb	0.004	0.996	0.000
S10.7 Multiple superficial injuries of neck	0.004	0.996	0.000
S10.1 Other and unspecified superficial injuries of throat	0.004	0.996	0.000
S10.0 Contusion of throat	0.004	0.996	0.000
S17 Crushing injury of neck	0.004	0.996	0.000
S15 Injury of blood vessels at neck level	0.004	0.996	0.000
S18 Traumatic amputation at neck level	0.004	0.996	0.000
S16 Injury of muscle and tendon at neck level	0.004	0.996	0.000
C66 Malignant neoplasm of ureter	0.000	0.996	0.004
O34 Maternal care for known or suspected abnormality of pelvic organs	0.004	0.996	0.000
H65.0 Acute serous otitis media	0.004	0.996	0.000
S62.81 Fracture of other and unspecified parts of wrist and hand (open)	0.004	0.996	0.000
S62.11 Fracture of other carpal bone(s) (open)	0.004	0.996	0.000
S62.10 Fracture of other carpal bone(s) (closed)	0.004	0.996	0.000
S62.80 Fracture of other and unspecified parts of wrist and hand (closed)	0.004	0.996	0.000
S36 Injury of intra-abdominal organs	0.004	0.996	0.000
S60-S69 Injuries to the wrist and hand	0.004	0.996	0.000
Z85.5 Personal history of malignant neoplasm of urinary tract	0.000	0.996	0.004
T08-T14 Injuries to unspecified part of trunk, limb or body region	0.004	0.996	0.000
H65.2 Chronic serous otitis media	0.004	0.996	0.000
S30.8 Other superficial injuries of abdomen, lower back and pelvis	0.004	0.996	0.000
S30 Superficial injury of abdomen, lower back and pelvis	0.004	0.996	0.000
T93 Sequelae of injuries of lower limb	0.004	0.996	0.000
S11 Open wound of neck	0.004	0.996	0.000
T51-T65 Toxic effects of substances chiefly nonmedicinal as to source	0.004	0.996	0.000
T02 Fractures involving multiple body regions	0.004	0.996	0.000
S31 Open wound of abdomen, lower back and pelvis	0.004	0.996	0.000
T23 Burn and corrosion of wrist and hand	0.004	0.996	0.000
C65 Malignant neoplasm of renal pelvis	0.000	0.996	0.004
S67 Crushing injury of wrist and hand	0.004	0.996	0.000
S62.21 Fracture of first metacarpal bone (open)	0.004	0.996	0.000
S39.8 Other specified injuries of abdomen, lower back and pelvis	0.004	0.996	0.000
T21 Burn and corrosion of trunk	0.004	0.996	0.000
T33-T35 Frostbite	0.004	0.996	0.000
T26-T28 Burns and corrosions confined to eye and internal organs	0.004	0.996	0.000
S62.71 Multiple fractures of fingers (open)	0.004	0.996	0.000
T85.8 Other complications of internal prosthetic devices, implants and grafts, not elsewhere classified	0.000	0.996	0.004
J34.8 Other specified disorders of nose and nasal sinuses	0.000	0.996	0.004
S70-S79 Injuries to the hip and thigh	0.004	0.996	0.000
S62.41 Multiple fractures of metacarpal bones (open)	0.004	0.996	0.000
O34.0 Maternal care for congenital malformation of uterus	0.004	0.996	0.000
S13.1 Dislocation of cervical vertebra	0.004	0.996	0.000
C82.9 Follicular non-Hodgkin's lymphoma, unspecified	0.003	0.996	0.000
E23.3 Hypothalamic dysfunction, not elsewhere classified	0.004	0.996	0.000
E23.1 Drug-induced hypopituitarism	0.004	0.996	0.000
S39.9 Unspecified injury of abdomen, lower back and pelvis	0.004	0.996	0.000
E23.7 Disorder of pituitary gland, unspecified	0.004	0.996	0.000
S37 Injury of urinary and pelvic organs	0.004	0.996	0.000
E23.6 Other disorders of pituitary gland	0.004	0.996	0.000
S38 Crushing injury and traumatic amputation of part of abdomen, lower back and pelvis	0.004	0.996	0.000
S35 Injury of blood vessels at abdomen, lower back and pelvis level	0.004	0.996	0.000
S34 Injury of nerves and lumbar spinal cord at abdomen, lower back and pelvis level	0.004	0.996	0.000
S33 Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis	0.004	0.996	0.000
T22 Burn and corrosion of shoulder and upper limb, except wrist and hand	0.004	0.996	0.000
C64 Malignant neoplasm of kidney, except renal pelvis	0.000	0.996	0.004
H66 Suppurative and unspecified otitis media	0.004	0.996	0.000
T25 Burn and corrosion of ankle and foot	0.004	0.996	0.000
S13.6 Sprain and strain of joints and ligaments of other and unspecified parts of neck	0.004	0.996	0.000
T93.8 Sequelae of other specified injuries of lower limb	0.004	0.996	0.000
T00 Superficial injuries involving multiple body regions	0.004	0.996	0.000
T15-T19 Effects of foreign body entering through natural orifice	0.004	0.996	0.000
H65-H75 Diseases of middle ear and mastoid	0.004	0.996	0.000
T24 Burn and corrosion of hip and lower limb, except ankle and foot	0.004	0.996	0.000
T90-T98 Sequelae of injuries, of poisoning and of other consequences of external causes	0.004	0.996	0.000
T79-T79 Certain early complications of trauma	0.004	0.996	0.000
N48.6 Balanitis xerotica obliterans	0.004	0.996	0.000
S67.0 Crushing injury of thumb and other finger(s)	0.004	0.996	0.000
S12 Fracture of neck	0.004	0.996	0.000
S36.4 Injury of small intestine	0.004	0.996	0.000
T20.2 Burn of second degree of head and neck	0.003	0.996	0.000
S62.01 Fracture of navicular [scaphoid] bone of hand (open)	0.003	0.996	0.000
T56 Toxic effect of metals	0.003	0.996	0.000
Q51 Congenital malformations of uterus and cervix	0.003	0.996	0.000
T20.7 Corrosion of third degree of head and neck	0.003	0.996	0.000
T20.6 Corrosion of second degree of head and neck	0.003	0.996	0.000
T20.5 Corrosion of first degree of head and neck	0.003	0.996	0.000
T20.4 Corrosion of unspecified degree of head and neck	0.003	0.996	0.000
T20.3 Burn of third degree of head and neck	0.003	0.996	0.000
T20.1 Burn of first degree of head and neck	0.003	0.996	0.000
Y43 Primarily systemic agents	0.003	0.996	0.000
T06 Other injuries involving multiple body regions, not elsewhere classified	0.003	0.996	0.000
T05 Traumatic amputations involving multiple body regions	0.003	0.996	0.000
T04 Crushing injuries involving multiple body regions	0.003	0.996	0.000
T03 Dislocations, sprains and strains involving multiple body regions	0.003	0.996	0.000
T01 Open wounds involving multiple body regions	0.003	0.996	0.000
T07 Unspecified multiple injuries	0.003	0.996	0.000
S62.20 Fracture of first metacarpal bone (closed)	0.003	0.997	0.000
S62.70 Multiple fractures of fingers (closed)	0.003	0.997	0.000
S13.5 Sprain and strain of thyroid region	0.003	0.997	0.000
S13.3 Multiple dislocations of neck	0.003	0.997	0.000
S13.2 Dislocation of other and unspecified parts of neck	0.003	0.997	0.000
S13.0 Traumatic rupture of cervical intervertebral disk	0.003	0.997	0.000
S50-S59 Injuries to the elbow and forearm	0.003	0.997	0.000
M19.02 Primary arthrosis of other joints (Upper arm)	0.003	0.997	0.000
O34.1 Maternal care for tumour of corpus uteri	0.003	0.997	0.000
T02.4 Fractures involving multiple regions of both upper limbs	0.003	0.997	0.000
S19 Other and unspecified injuries of neck	0.003	0.997	0.000
S39.7 Other multiple injuries of abdomen, lower back and pelvis	0.003	0.997	0.000
S39.6 Injury of intra-abdominal organ(s) with pelvic organ(s)	0.003	0.997	0.000
T93.9 Sequelae of unspecified injury of lower limb	0.003	0.997	0.000
T11 Other injuries of upper limb, level unspecified	0.003	0.997	0.000
S73 Dislocation, sprain and strain of joint and ligaments of hip	0.003	0.997	0.000
O34.8 Maternal care for other abnormalities of pelvic organs	0.003	0.997	0.000
S36.40 Injury of small intestine (without open wound into cavity)	0.003	0.997	0.000
F17.2 Dependence syndrome	0.003	0.997	0.000
M19.0 Primary arthrosis of other joints	0.003	0.997	0.000
C68 Malignant neoplasm of other and unspecified urinary organs	0.000	0.997	0.003
H74 Other disorders of middle ear and mastoid	0.003	0.997	0.000
S62.40 Multiple fractures of metacarpal bones (closed)	0.003	0.997	0.000
T23.0 Burn of unspecified degree of wrist and hand	0.003	0.997	0.000
T63 Toxic effect of contact with venomous animals	0.003	0.997	0.000
T54 Toxic effect of corrosive substances	0.003	0.997	0.000
S15.9 Injury of unspecified blood vessel at neck level	0.003	0.997	0.000
S15.8 Injury of other blood vessels at neck level	0.003	0.997	0.000
S15.7 Injury of multiple blood vessels at neck level	0.003	0.997	0.000
S15.3 Injury of internal jugular vein	0.003	0.997	0.000
S15.2 Injury of external jugular vein	0.003	0.997	0.000
S15.1 Injury of vertebral artery	0.003	0.997	0.000
S15.0 Injury of carotid artery	0.003	0.997	0.000
S17.9 Crushing injury of neck, part unspecified	0.003	0.997	0.000
S17.8 Crushing injury of other parts of neck	0.003	0.997	0.000
S17.0 Crushing injury of larynx and traches	0.003	0.997	0.000
S30.0 Contusion of lower back and pelvis	0.003	0.997	0.000
T23.3 Burn of third degree of wrist and hand	0.003	0.997	0.000
T56.8 Other metals	0.003	0.997	0.000
T29-T32 Burns and corrosions of multiple and unspecified body regions	0.003	0.997	0.000
H74.0 Tympanosclerosis	0.003	0.997	0.000
S32 Fracture of lumbar spine and pelvis	0.003	0.997	0.000
H25.9 Senile cataract, unspecified	0.000	0.997	0.003
O34.9 Maternal care for abnormality of pelvic organ, unspecified	0.003	0.997	0.000
O34.6 Maternal care for abnormality of vagina	0.003	0.997	0.000
O34.5 Maternal care for other abnormalities of gravid uterus	0.003	0.997	0.000
T21.1 Burn of first degree of trunk	0.003	0.997	0.000
H65.4 Other chronic nonsuppurative otitis media	0.003	0.997	0.000
S31.1 Open wound of abdominal wall	0.003	0.997	0.000
S39.0 Injury of muscle and tendon of abdomen, lower back and pelvis	0.003	0.997	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations